Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature)
Background. Many studies concerning molecular-biological markers in colorectal cancer (CRC) were performed over the past decade. Вcl-2 protein (B-cell lymphoma 2) was one of the most studied molecular-biological markers and attracted the attention of different specialties as on studying carcinogenes...
Main Authors: | Anna D Darenskaia, Natal'ia V Dobrova, Evgeniia V Stepanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2019-03-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/33527/pdf_1 |
Similar Items
-
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
by: Kulsoom B, et al.
Published: (2018-03-01) -
Bax protein as a prognostic marker in colorectal cancer: characteristics, role in apoptosis regulation, and correlation with disease prognosis (literature review)
by: A. D. Darenskaya, et al.
Published: (2019-06-01) -
Evaluation of Bcl2/BAX genes expression ratio as a marker of inflammatory bowel disease
by: Fariba Javadinia, et al.
Published: (2019-06-01) -
Apoptosis Regulators Bcl-2 and Caspase-3
by: Piret Hussar
Published: (2022-09-01) -
MicroRNA‐498 reduces the proliferation and invasion of colorectal cancer cells via targeting Bcl‐2
by: Tongsheng Wang, et al.
Published: (2020-01-01)